By elucidating the mechanisms by which ZFAS1 and STAT3 contribute to imatinib resistance, our study offers new insights into the metabolic adaptations of CML cells. The gene discussed is ZFAS1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.